BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Summary of revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue
Total	$ 4,165,706	$ 1,616,141
Research and development services (over-time)
Disaggregation of Revenue
Total	105,695	263,713
Clinical laboratory testing services (point-in-time)
Disaggregation of Revenue
Total	1,873,722	578,370
Clinical laboratory testing services (over-time)
Disaggregation of Revenue
Total	1,326,400	194,400
Supply chain
Disaggregation of Revenue
Total	411,547	32,942
Asset marking
Disaggregation of Revenue
Total	105,522	151,758
Diagnostic test kits
Disaggregation of Revenue
Total	$ 342,820	$ 394,958